Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Mulstidisciplinary Medication Assessment Review in Surgery Departments
Sponsor: Centre Hospitalier Universitaire de Nīmes
Summary
The presence of a clinical pharmacist (for their pharmacological expertise) and a general practitioner (for their somatic expertise) in surgery departments would contribute to improve the management of medications in elderly patients.
Official title: Implementation and Impact of Multidisciplinary Medication Review in Surgery Departments on Medication Management of Elderly Patients
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
INTERVENTIONAL
Enrollment
297
Start Date
2022-07-18
Completion Date
2027-07
Last Updated
2025-08-20
Healthy Volunteers
No
Conditions
Interventions
Mutlidisciplinary medication Review (MMR)
The clinical pharmacist performs medication reconciliation and pharmaceutical analysis. The physician performs a clinical examination and analysis of the medical record. Both participate in a collaborative interview. The hospital physician calls the community pharamcist to discuss proposed changes on the order and to establish a new prescription. At the end of the stay, the clinical pharmacist will conduct an exit interview with the patient. Three months after discharge, the patient's community pharmacist will be contacted to assess whether the changes proposed in the MMR were accepted
Mutlidisciplinary medication Review (MMR) with community pharmacist follow-up
Multidisciplinary medication review (MMR) The clinical pharmacist performs medication reconciliation and pharmaceutical analysis. The physician performs a clinical examination and analysis of the medical record. Both participate in a collaborative interview. The hospital physician calls the community physician to discuss proposed changes on the order and to establish a new prescription. At the end of the stay, the clinical pharmacist will conduct an exit interview with the patient. Community follow-up A summary of the follow-up report stating the therapeutic modifications (called below multidisciplinary correspondence documents) will be sent to the community pharmacist and physician. Within 2 months of discharge, the pharmacist performs a follow-up of medication changes accepted and not accepted by the community physician. Three months after discharge, the patient's community pharmacist will be contacted to assess whether the changes proposed in the MMR were accepted.
Locations (4)
Chu de Grenoble
Grenoble, France
CHU de Montpellier
Montpellier, France
Nimes University Hospital
Nîmes, France
CHU de Toulouse
Toulouse, France